Epidemiologists are at the forefront of disease surveillance and control, applying scientific methods to track the spread of illnesses and understand their impact on populations. Their work involves identifying the source of outbreaks, analyzing patterns of transmission, and determining who is at greatest risk. By collecting and interpreting data from communities, hospitals, and laboratories, epidemiologists provide the critical evidence needed to inform public health decisions. They are instrumental in designing strategies that mitigate the effects of both infectious and non-infectious diseases, from pandemic viruses to chronic conditions like diabetes and heart disease.
With the increasing threat of global health emergencies, the role of epidemiologists has expanded to include real-time data modeling, predictive analytics, and international collaboration. They help shape public health policies and preparedness plans by evaluating the effectiveness of interventions such as social distancing, vaccination programs, and hygiene campaigns. Their findings are essential in crafting guidelines that protect both local and global populations. Additionally, epidemiologists often contribute to health education initiatives, aiming to inform communities and empower individuals to make healthier choices. Their efforts not only curb disease outbreaks but also foster resilience in health systems, ensuring that responses are swift, science-driven, and equitable. As the global health landscape evolves, their expertise remains vital to safeguarding communities against both current and future threats.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States